In COVID-19, severely ill patients have significantly lower levels of SIRT3, and its levels are negatively correlated with CRP and procalcitonin levels, indicating the association of serum SIRT3 levels with clinical outcomes and prognosis in COVID-19 patients [36]. The gene discussed is SIRT3; the disease is COVID-19.